Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Joshua D. Amason"'
Autor:
Teresa L Burgess, Joshua D Amason, Jeffrey S Rubin, Damien Y Duveau, Laurence Lamy, David D Roberts, Catherine L Farrell, James Inglese, Craig J Thomas, Thomas W Miller
Publikováno v:
PLoS ONE, Vol 15, Iss 4, p e0226661 (2020)
CD47 is an immune checkpoint protein that downregulates both the innate and adaptive anti-tumor immune response via its counter receptor SIRPα. Biologics, including humanized CD47 monoclonal antibodies and decoy SIRPα receptors, that block the SIRP
Externí odkaz:
https://doaj.org/article/111b8f5d693740d9a3ac2f6213358045
Autor:
Thomas W Miller, Joshua D Amason, Elsa D Garcin, Laurence Lamy, Patricia K Dranchak, Ryan Macarthur, John Braisted, Jeffrey S Rubin, Teresa L Burgess, Catherine L Farrell, David D Roberts, James Inglese
Publikováno v:
PLoS ONE, Vol 14, Iss 7, p e0218897 (2019)
CD47 is an immune checkpoint molecule that downregulates key aspects of both the innate and adaptive anti-tumor immune response via its counter receptor SIRPα, and it is expressed at high levels in a wide variety of tumor types. This has led to the
Externí odkaz:
https://doaj.org/article/72f1809b5d2d4362be19df63504e4ef9
Autor:
Catherine L. Farrell, Jeffrey S. Rubin, Damien Y. Duveau, David D. Roberts, Joshua D. Amason, Teresa L. Burgess, Craig J. Thomas, Thomas W. Miller, Laurence Lamy, James Inglese
Publikováno v:
PLoS ONE
PLoS ONE, Vol 15, Iss 4, p e0226661 (2020)
PLoS ONE, Vol 15, Iss 4, p e0226661 (2020)
CD47 is an immune checkpoint protein that downregulates both the innate and adaptive anti-tumor immune response via its counter receptor SIRPα. Biologics, including humanized CD47 monoclonal antibodies and decoy SIRPα receptors, that block the SIRP
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::609a9e91e8bf3cb90a9fcc591dccf3f0
https://pubmed.ncbi.nlm.nih.gov/32240171
https://pubmed.ncbi.nlm.nih.gov/32240171
Autor:
Elsa D. Garcin, Laurence Lamy, Joshua D. Amason, James Inglese, Ryan MacArthur, Jeffrey S. Rubin, Teresa L. Burgess, Catherine L. Farrell, Thomas W. Miller, Patricia Dranchak, John C. Braisted, David D. Roberts
Publikováno v:
PLoS ONE
PLoS ONE, Vol 14, Iss 7, p e0218897 (2019)
PLoS ONE, Vol 14, Iss 7, p e0218897 (2019)
CD47 is an immune checkpoint molecule that downregulates key aspects of both the innate and adaptive anti-tumor immune response via its counter receptor SIRPα, and it is expressed at high levels in a wide variety of tumor types. This has led to the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a9f71df68c89b0c1dc0cddf807f4f74
http://europepmc.org/articles/PMC6611588
http://europepmc.org/articles/PMC6611588